secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gazelle Parent, Inc. (OBX)
CIK:        0002130606
Form:       8-K
Filed at:   2026-08-03T21:08:10+00:00
Accession:  0001193125-26-330810
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.01, 2.02, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Obsidian Therapeutics completes reverse merger with Legacy Obsidian and Galera; begins trading on Nasdaq under OBX
--------------------------------------------------------------------------------

- Mergers closed Aug 3, 2026; Legacy Obsidian shareholders received 0.1383 shares of Parent per share; Legacy Galera shareholders received 0.7019 shares per share.
- Concurrent PIPE of $350M from qualified investors; post-merger ownership: Legacy Obsidian ~51.6%, PIPE investors ~47.2%, Legacy Galera ~1.2%.
- New board of six directors appointed, led by Chairperson Maria Fardis; includes CEO Madan Jagasia and other Legacy Obsidian designees.
- Galera shareholders receive CVRs for 80% of net proceeds from Legacy Product (5 years) and 95% from Supportive-Care Product Divestiture (10 years).
- KPMG appointed as independent auditor; Parent Common Stock to trade on Nasdaq under ticker OBX starting Aug 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/0001193125-26-330810-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-330810

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer